Anne Dupraz-Poiseau
Nessuna posizione attualmente
Provenienza dei contatti di primo grado di Anne Dupraz-Poiseau
| Entità | Tipo di entità | Settore Industriale | |
|---|---|---|---|
| Subsidiary | Pharmaceuticals: Major | 26 | |
Voisin Consulting, Inc.
 Voisin Consulting, Inc. Miscellaneous Commercial ServicesCommercial Services Voisin Consulting, Inc. provides product development consulting services. It guides biotechnology, pharmaceutical and medical technology manufacturers throughout product development and commercialization. The company was founded by Emanuelle M. Viosin in 1997 and is headquartered in Cambridge, MA.
1
| Private Company | Miscellaneous Commercial Services | 1 |
Grafico delle società connesse in secondo grado
Relazione in diverse aziende
Società connesse a Anne Dupraz-Poiseau tramite i suoi contatti personali
| Società | Settore | Persone collegate | Posizione principale |
|---|---|---|---|
| JUNIPER PHARMACEUTICALS INC | Pharmaceuticals: Major | Chairman Chief Executive Officer | |
Genentech, Inc.
 Genentech, Inc. BiotechnologyHealth Technology Genentech, Inc. develops, manufactures and markets pharmaceutical products for life-threatening medical conditions. It studies various areas including oncology, immunology, neuroscience, ophthalmic diseases, microbial pathogenesis, metabolic diseases, cardiovascular diseases, and opportunistic areas. The company was founded by Herb W. Boyer and Robert A. Swanson in 1976 and is headquartered in South San Francisco, CA. | Biotechnology | Director/Board Member | |
| ALEXION PHARMACEUTICALS, INC. | Pharmaceuticals: Major | Chief Executive Officer Corporate Officer/Principal | |
| OSIRIS THERAPEUTICS, INC. | Biotechnology | Chief Operating Officer Corporate Officer/Principal | |
| TRANSGENE | Biotechnology | General Counsel | |
Genzyme Corp.
 Genzyme Corp. Medical SpecialtiesHealth Technology Genzyme Corp. engages in development and manufacture of specialty therapeutic, surgical and diagnostic product. It serves in the areas of rare genetic diseases, multiple sclerosis, cardiovascular diseases and endocrinology. The company was founded on June 8, 1981 and is headquartered in Cambridge, MA. | Medical Specialties | Corporate Officer/Principal Corporate Officer/Principal | |
| PORTOLA PHARMACEUTICALS, INC. | Pharmaceuticals: Major | President | |
| GSK PLC | Pharmaceuticals: Major | Corporate Officer/Principal Chief Tech/Sci/R&D Officer | |
Harvard University
 Harvard University Other Consumer ServicesConsumer Services Harvard University engages in the provision of teaching and research. It has twelve degree-granting Schools in addition to the Radcliffe Institute for Advanced Study, offering a global education. The university was founded in 1636 and is headquartered in Cambridge, MA. | College/University | Undergraduate Degree Undergraduate Degree | |
| GW PHARMACEUTICALS PLC | Pharmaceuticals: Major | Director/Board Member | |
Arthur Andersen LLP
 Arthur Andersen LLP Miscellaneous Commercial ServicesCommercial Services Arthur Andersen LLP used to provide accounting services. It was also into consulting services for clients that operate businesses throughout the United States and around the world. Arthur Andersen was founded in 1913 and was headquartered in Chicago, IL. | Miscellaneous Commercial Services | Corporate Officer/Principal Corporate Officer/Principal | |
Orchard Therapeutics (Europe) Ltd.
 Orchard Therapeutics (Europe) Ltd. BiotechnologyHealth Technology Orchard Therapeutics (Europe) Ltd. researches on transformative gene therapies. Its services include stem cell technology, gene therapy, eradicating orphan diseases, and paediatric diseases. The company was founded by Andrea Spezzi and Nicolas Koebel on September 1, 2015 and is headquartered in London, the United Kingdom. | Biotechnology | President Chairman Director/Board Member Director/Board Member Chief Executive Officer Chief Executive Officer Director/Board Member Founder Founder Director/Board Member Director/Board Member Director/Board Member | |
| University of Cambridge | College/University | Doctorate Degree Graduate Degree Doctorate Degree | |
Alliance for Regenerative Medicine
 Alliance for Regenerative Medicine Medical/Nursing ServicesHealth Services ARM is a Washington, DC-based multi-stakeholder advocacy organization that promotes global initiatives necessary to facilitate access to life-giving advances in regenerative medicine. The organization promotes legislative, regulatory reimbursement, investment, technical, and other initiatives to accelerate the development of safe and effective regenerative medicine technologies. ARM also works to increase public understand- ing of the field and its potential to transform human healthcare. Prior to the formation of ARM in 2009, there was a need for more coordinated and cohesive advocacy representing the interests of the companies, research institutions, investors and patient groups that comprise the entire regenerative medicine community. Today ARM has more than 140 members and is the leading global advocacy organization in this field. | Medical/Nursing Services | Director/Board Member Director/Board Member Director/Board Member | |
Orchard Therapeutics North America
 Orchard Therapeutics North America BiotechnologyHealth Technology Part of Orchard Therapeutics Plc, Orchard Therapeutics North America provides biotechnology research services. The company is based in Boston, MA. The CEO of the company is Bobby Gaspar. | Biotechnology | Director/Board Member President Chief Executive Officer | |
| University of Maryland | College/University | Graduate Degree Undergraduate Degree | |
| King's College London | College/University | Graduate Degree Graduate Degree | |
| University College London | College/University | Doctorate Degree Doctorate Degree | |
| Stanford University School of Medicine | College/University | Corporate Officer/Principal Doctorate Degree | |
| Université Paris 1 Panthéon-Sorbonne | College/University | Graduate Degree | |
| TXCELL | Miscellaneous Commercial Services | General Counsel | |
| ACACIA PHARMA GROUP PLC | Pharmaceuticals: Other | Director/Board Member | |
Acacia Pharma Ltd.
 Acacia Pharma Ltd. Pharmaceuticals: MajorHealth Technology Acacia Pharma Ltd. develops supportive care product opportunities for post-surgical and cancer patients. It specializes in the discovery and development of cancer supportive care product opportunities based on established drugs. The firm’s product pipeline addresses supportive care indications, such as post-operative and chemotherapy-induced nausea and vomiting, xerostomia and cachexia. The company was founded by Andrew Muncey, Julian Clive Gilbert and Robert William Gristwood in 2006 and is headquartered in Cambridge, the United Kingdom. | Pharmaceuticals: Major | Director/Board Member | |
| ELSALYS BIOTECH | Pharmaceuticals: Major | Chief Operating Officer | |
| University of New Hampshire | College/University | Undergraduate Degree | |
Atalanta Therapeutics, Inc.
 Atalanta Therapeutics, Inc. Miscellaneous Commercial ServicesCommercial Services Atalanta Therapeutics, Inc. develops RNA interference based therapeutics to treat neurodegenerative diseases. The company is based in Boston, MA. The company was founded by Neil Aronin, Craig C. Mello, Anastasia Khvorova, Jim Glasheen. The CEO is Alicia Secor. | Miscellaneous Commercial Services | Chief Executive Officer | |
| Foundation For Prader-Willi Research, Inc. | Director/Board Member | ||
| G1 THERAPEUTICS, INC. | Pharmaceuticals: Major | Director/Board Member | |
| D'Amore-Mckim School of Business | College/University | Masters Business Admin | |
| FATE THERAPEUTICS, INC. | Biotechnology | General Counsel | |
Xention Pharma Ltd.
 Xention Pharma Ltd. Pharmaceuticals: MajorHealth Technology Xention Pharma Ltd. develops and researches drugs. The firm develops novel therapies for the treatment of atrial fibrillation; modulators of IKur and IKACh for atrial fibrillation. The company was founded by John W. Word and is headquartered in Newmarket, the United kingdom. | Pharmaceuticals: Major | Director/Board Member | |
| Saint Augustine's University | College/University | Undergraduate Degree | |
| HISTOGEN INC. | Biotechnology | Chief Tech/Sci/R&D Officer | |
SanBio, Inc.
 SanBio, Inc. Medical/Nursing ServicesHealth Services SanBio, Inc. develops regenerative therapies for neurological disorders. The firm is focused on cell therapies for neurological disorders such as stroke, traumatic brain injury, eye disease, and Parkinson's disease. Its product pipeline includes SB623 and SB618. The company was founded by Keita Mori and Toru Kawanishi in 2001 and is headquartered in Mountain View, CA. | Medical/Nursing Services | Corporate Officer/Principal | |
Genethon
 Genethon BiotechnologyHealth Technology Genethon is a biotherapy research and development firm, which engages in the design, development, and production of gene therapy treatments for rare diseases. It specializes in neuromuscular diseases, immune system or blood disorders, eye disorders, and liver and nervous system diseases. The company was founded in 1990 and is headquartered in Evry, France. | Biotechnology | Chief Tech/Sci/R&D Officer | |
| VIRACTA THERAPEUTICS, INC. | Biotechnology | Chief Executive Officer | |
| Gateway Fund Co. Pte Ltd. | Corporate Officer/Principal | ||
Arvelle Therapeutics International GmbH
 Arvelle Therapeutics International GmbH BiotechnologyHealth Technology Arvelle Therapeutics GmbH provides treatment for patients suffering form CNS disorders. The company was founded by Ilise Lombrado, Gregory Mark Weinhoff and Mark Altmeyer and is headquartered in Basel, Switzerland. | Biotechnology | Director/Board Member | |
NodThera Ltd.
 NodThera Ltd. BiotechnologyHealth Technology NodThera Ltd. researches and develops novel inhibitors of the NLRP3 inflammasome. The company is headquartered in Little Chesterford, the United Kingdom. | Biotechnology | Director/Board Member | |
| SAGIMET BIOSCIENCES INC. | Pharmaceuticals: Major | Chief Executive Officer | |
Ciwit BV
 Ciwit BV Internet Software/ServicesTechnology Services Ciwit BV provides electronic data capture platform for medical research. The company was founded by Derk Arts in 2011 and is headquartered in Amsterdam, the Netherlands. | Internet Software/Services | Director/Board Member | |
Schering-Plough Biopharma
 Schering-Plough Biopharma Miscellaneous Commercial ServicesCommercial Services Part of Merck & Co., Inc., Schering-Plough Biopharma is a company that provides pharmaceutical research services. The company is based in Kenilworth, NJ. | Miscellaneous Commercial Services | President | |
Tenpoint Therapeutics Ltd.
 Tenpoint Therapeutics Ltd. BiotechnologyHealth Technology Tenpoint Therapeutics Ltd. is a British biotechnology company that specializes in developing engineered cell-based therapies and in vivo reprogramming to restore vision for individuals with degenerative ocular diseases. The company is based in Cambridge, UK and was founded in 2020. Tenpoint Therapeutics brings together experts who are shaping the regenerative ocular medicine revolution and the technologies that are driving it. The company's focus is on replacing diseased cells with healthy ones to permanently restore vision. Eddy Anglade has been the CEO of the company since 2023. | Biotechnology | Director/Board Member |
Statistiche
Distribuzione geografica
| Stati Uniti | 27 |
| Regno Unito | 12 |
| Francia | 7 |
| Israele | 2 |
| Singapore | 2 |
Settori
| Health Technology | 28 |
| Consumer Services | 12 |
| Commercial Services | 5 |
| Health Services | 3 |
| Technology Services | 2 |
Posizioni
| Director/Board Member | 117 |
| Corporate Officer/Principal | 56 |
| Independent Dir/Board Member | 47 |
| Chief Executive Officer | 29 |
| President | 20 |
Contatti più connessi
| Insiders | |
|---|---|
| Steven Altschuler | 27 |
| James Geraghty | 25 |
| Charles Rowland | 25 |
| Alexander Pasteur | 19 |
| Marc Dunoyer | 16 |
| Frank Thomas | 14 |
| Mark Rothera | 14 |
| Stewart Craig | 13 |
| John Curnutte | 12 |
| Joanne Beck | 12 |
| Alicia Secor | 12 |
| Elise T. Wang | 10 |
| Fulvio Mavilio | 10 |
| Simone Song | 9 |
| Jason Meyenburg | 9 |
- Borsa valori
- Insiders
- Anne Dupraz-Poiseau
- Connessioni Società
